REGENERON PHARMACEUTICALS, INC. (REGN) /
The profitability of REGENERON PHARMACEUTICALS, INC. over the past 10 years
Chart REGENERON PHARMACEUTICALS, INC.: gross profit, operating income, net income, fiscal 2016–2025 Open the chart →REGENERON PHARMACEUTICALS, INC. reported net income of $4.5B in fiscal 2025, the latest fiscal year on file. That year it had operating income of $3.58B. It reported a profit in all 10 years shown. Its highest net income in these years was $8.08B, in fiscal 2021.
Year by year
| Fiscal year | Gross profit | Operating income | Net income |
|---|---|---|---|
| 2025ended Dec 31, 2025 | — | $3.58B | $4.5B |
| 2024ended Dec 31, 2024 | — | $3.99B | $4.41B |
| 2023ended Dec 31, 2023 | — | $4.05B | $3.95B |
| 2022ended Dec 31, 2022 | — | $4.74B | $4.34B |
| 2021ended Dec 31, 2021 | — | $8.95B | $8.08B |
| 2020ended Dec 31, 2020 | — | $3.58B | $3.51B |
| 2019ended Dec 31, 2019 | $6.15B* | $2.21B | $2.12B |
| 2018ended Dec 31, 2018 | $4.91B* | $2.53B | $2.44B |
| 2017ended Dec 31, 2017 | $5.67B* | $2.08B | $1.2B |
| 2016ended Dec 31, 2016 | $4.67B* | $1.33B | $895.5M |
Fiscal years as REGENERON PHARMACEUTICALS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on REGENERON PHARMACEUTICALS, INC.
- The revenue of REGENERON PHARMACEUTICALS, INC.
- The cash flow of REGENERON PHARMACEUTICALS, INC.
- The debt of REGENERON PHARMACEUTICALS, INC.
- The dividends of REGENERON PHARMACEUTICALS, INC.
- All of REGENERON PHARMACEUTICALS, INC.'s financials, charted
Companies of a similar size
- UPSUNITED PARCEL SERVICE INC
- TRVTravelers Companies, Inc.
- EOGEOG RESOURCES, INC.
- MCOMoody’s Corporation
- CDNSCADENCE DESIGN SYSTEMS, INC.
Not investment advice. This page shows what REGENERON PHARMACEUTICALS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.